Amgen 4Q 4Q Revenues: $3.8 billion (+2%) 4Q Earnings: $931 million (+1%) FY Revenues: $14.6 billion (-2%) FY Earnings: $4.6 billion (+14%) Comments: Product sales were up 2% to $3.7 billion in 4Q09. Sales in the U.S. were $2.9 billion (-1%) for the quarter, while International sales were up 11% to $861 million. Foreign exchange positively impacted 4Q09 sales by $35 million. Worldwide sales of Aranesp were $648 million in the quarter (-8%). Sales of Epogen were up 9% to $703 millio...